Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study
- DOI
- 10.1038/s41467-026-75291-3
- Published
- 2026-07-31
- Container
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-75291-3,
title = {Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study},
author = {Philip L. Molyneaux and Nikhil A. Hirani and Collin C. K. Chia and Tejaswini Kulkarni and Tanzira Zaman and Robert J. Kaner and Ana Lucia Coelho and Yago Amigo Pinho Jannini-Sa and Brian Windsor and Sydney Kruger and Dale J. Christensen and Steven A. Shoemaker and Cory M. Hogaboam and BreAnne MacKenzie and Andreas Günther},
year = {2026},
journal = {Nature Communications},
doi = {10.1038/s41467-026-75291-3},
url = {https://doi.org/10.1038/s41467-026-75291-3}
}RIS
TY - JOUR TI - Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study AU - Philip L. Molyneaux AU - Nikhil A. Hirani AU - Collin C. K. Chia AU - Tejaswini Kulkarni AU - Tanzira Zaman AU - Robert J. Kaner AU - Ana Lucia Coelho AU - Yago Amigo Pinho Jannini-Sa AU - Brian Windsor AU - Sydney Kruger AU - Dale J. Christensen AU - Steven A. Shoemaker AU - Cory M. Hogaboam AU - BreAnne MacKenzie AU - Andreas Günther PY - 2026 JO - Nature Communications DO - 10.1038/s41467-026-75291-3 UR - https://doi.org/10.1038/s41467-026-75291-3 ER -
APA
Molyneaux, P. L., Hirani, N. A., Chia, C. C. K., Kulkarni, T., Zaman, T., Kaner, R. J., Coelho, A. L., Jannini-Sa, Y. A. P., Windsor, B., Kruger, S., Christensen, D. J., Shoemaker, S. A., Hogaboam, C. M., MacKenzie, B., & Günther, A. (2026). Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study. Nature Communications. https://doi.org/10.1038/s41467-026-75291-3
Source records
- crossref · retrieved 2026-09-26T02:26:49.876Z